Ipsen Global - A Biopharmaceutical Company | Innovation for Patient Care

WHO WE ARE

As a mid-sized global biopharmaceutical company, Ipsen improves patients’ lives through research, innovation and the development of transformative medicines in Oncology, Rare Disease and Neuroscience.

WHAT WE DO

WHAT WE DO

Improving people’s lives and health outcomes by focusing on areas of high unmet medical need, we are accelerating our momentum and rapidly boosting our pipeline to bring the full potential of our innovative medicines to patients.

Author Image

Our strategy has been instrumental in making us a leader in our field. Our global presence, resources, expertise and strong track record commercializing our medicines are resulting in a real impact for people living with high unmet medical needs. We’re leveraging the full force of Ipsen’s infrastructure, innovation and passion to develop new therapies and valuable collaborations.

David Loew

CEO

PATIENTS

Putting patients at the heart of our work

Our commitment to improving the lives and medical outcomes of patients is the driving force behind every decision made at Ipsen. We believe in working with patients, for patients, listening to their needs and involving their insights in the entire.

RESPONSIBILITY

RESPONSIBILITY

Shaping a more sustainable future

Ipsen is dedicated to safeguarding and preserving our planet. The Generation Ipsen ESG responsibility strategy lays out ambitious goals for the company in each of four pillars: Environment, Patients, People and Governance.

Careers at Ipsen

Ipsen offers a multitude of exciting opportunities for talented and motivated people in careers ranging from medial and clinical research to sales, marketing, finance, IT, HR and legal services. We are committed to providing our employees with a workplace that is welcoming, challenging and inclusive.

Discover trending stories

04 October 2024 2 mins read

Looking after a loved one with Progressive Familial Intrahepatic Cholestasis: Francesca’s Story

A few months after Eva Luna was born, her mother Francesca realised something wasn’t quite right. Within the span of a few days, their world was turned upside down when her daughter was diagnosed with a rare liver disease, known as Progressive Familial Intrahepatic Cholestasis (PFIC). Yet despite th

01 October 2024 1 mins read

Ipsen Achieves Its Record-High Score in 2024 S&P Global CSA, Setting New Company Benchmark 

We are proud to announce that Ipsen’s rating has reached an all-time high in the 2024 S&P Global Corporate Sustainability Assessment (CSA). Our score has increased by 4 points, from 57 in 2023 to 61 as od 19 September 2024, placing Ipsen in the 94th percentile of our industry. This remarkable achiev

23 September 2024 1 mins read

Ipsen’s Commitment to Zero Emissions: A Step Towards a Sustainable Future 

Zero Emission Day is a global initiative that raises awareness about the impact of human activities on climate change and promotes sustainable practices. 

12 September 2024 4 mins read

Partnering for Progress: The Importance of Collaboration in Primary Biliary Cholangitis (PBC) Awareness  

September is a month dedicated to raising awareness about Primary Biliary Cholangitis, I find myself reflecting on the challenges faced by those living with rare cholestatic disease. PBC Awareness Day on September 10th is not just a date on the calendar; it’s a reminder that understanding and suppor

11 September 2024 1 mins read

Breaking Barriers at Ipsen  

At Ipsen, our commitment to supporting para-athletes is a direct reflection of our core values. We believe in removing barriers and fostering an environment where diversity is celebrated, and every individual is supported to drive innovation. Our company culture encourages all employees to reach the

10 September 2024 3 mins read

Living with Neuroendocrine Cancer: Stephen’s story

It was only at 46 years old that Stephen was diagnosed with neuroendocrine cancer. Lovingly married to his wife and father to two sons freshly out of high school, in the prime of life with decades ahead of him, Stephen was shocked and confused by his diagnosis. His doctor told him he had 10 to 15 ye

03 September 2024 2 mins read

Provide Better Care: PBC Awareness Day 2024 

“We’re often asked, what is the PBC journey? And the challenge is that, well, the PBC journey doesn’t exist. There are thousands and thousands of patients around the world, and each of them have an individual journey.” 

21 August 2024 1 mins read

Taking Mindful Risks: Ipsen’s Pathway to Innovation 

At Ipsen, our strategy is anchored in the principle of taking calculated risks to drive innovation. We inspire our employees to embrace innovation and approach risk-taking with a strategic mindset, ensuring that it aligns with our company’s objectives and ethical guidelines.

08 August 2024 1 mins read

Winning Together at Ipsen 

At Ipsen, our commitment to supporting para-athletes is deeply aligned with our core values of cultivating and embracing diversity. By standing alongside these incredible athletes, we demonstrate our dedication to fostering an inclusive environment where every individual is valued and encouraged to

25 July 2024 1 mins read

Strong growth and expanding pipeline in the first half of 2024 drive raised guidance

The first six months of 2024 saw excellent sales growth of 9.5% at CER, and a core operating margin of 32.4%. In light of these strong results, we raised our 2024 total-sales guidance to over 7% growth, with a core operating margin of over 30%.